Verbatim response from Perplexity
No, legitimate compounded tirzepatide is no longer available through regular pharmacies or standard medical providers as of July 2026, because the FDA officially ended widespread compounding sales after the tirzepatide shortage was declared resolved in late 2024, with all grace periods and deadlines for pharmacies to stop production passing by March 19, 2025 [1][2][6].
Key Details:
- Regulatory Status: The FDA determined that Eli Lilly’s manufacturing expansion resolved the shortage, legally prohibiting pharmacies from regularly compounding tirzepatide unless there is a specific medical need (e.g., an allergy to an inactive ingredient in brand-name versions) [1][2].
- Legal Risk: While some online platforms (e.g., Amble, EllieMD, Willow, Mochi Health) still promote "variations" of tirzepatide, the FDA has warned that these are likely illegal "copycats" or replicas of commercially available drugs, exposing providers to legal risks [5].
- Safety Concerns: Compounded tirzepatide is not FDA-approved, unregulated, and may be counterfeit or unsafe, with serious health risks [2][9].
- Legitimate Alternatives: The only legitimate way to access tirzepatide is through FDA-approved brand-name medications: Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), obtainable via a prescription from a healthcare provider [1][3].
Recommendation:
Avoid purchasing tirzepatide from unverified sources claiming no prescription is needed or offering "research-grade" versions, as these are illegal and unsafe [2]. Instead, consult your doctor about Mounjaro or Zepbound, or explore other FDA-approved GLP-1 options like Wegovy (semaglutide) if cost or access is a barrier [3].
Brands to Consider:
- Mounjaro (Eli Lilly) – for diabetes
- Zepbound (Eli Lilly) – for weight loss
- Wegovy (Novo Nordisk) – alternative GLP-1 for weight loss
These are the only safe, legal, and effective options available today.